Impact of OCT4 and Its Related Signaling Pathways on Gastrointestinal Cancers: Focusing on Targeted Therapy

被引:7
作者
Cheshomi, Hamid [1 ]
Gholami, Omid [1 ]
Peyroshabani, Babak [2 ]
Rad, Abolfazl [1 ]
机构
[1] Sabzevar Univ Med Sci, Cellular & Mol Res Ctr, POB 9816745639, Sabzevar, Iran
[2] Sabzevar Univ Med Sci, Clin Res Dev Unit, Sabzevar, Iran
关键词
Colorectal cancer; Esophageal neoplasms; Stomach neoplasms; STEM-CELL MARKERS; HUMAN EMBRYONIC STEM; COLORECTAL-CANCER; GASTRIC-CANCER; COLON-CANCER; GENE-EXPRESSION; ESOPHAGEAL CANCER; MESENCHYMAL TRANSITION; PROGNOSTIC VALUE; PROSTATE-CANCER;
D O I
10.18502/ijaai.v19i3.3451
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
There are many pieces of evidence support the effect of cancer stem cells on the initiation and progression of cancer. However, related mechanisms involved in these phenomena are far more complicated to understand. The function of different stemness factorsin cancer stem cells (CSCs) and their complex associations at different levels of cancer have been reported. Therefore, it seems that focusing on one master factor would be more helpful to complete the puzzle of singling pathways in these cells. Octamer-binding transcription factor 4 (OCT4) also known as POU domain, class 5, transcription factor 1(POU5F1), one of these key pluripotency factors, has important roles in both embryogenesis and tumorigenesis. In this review, we gathered information about the association of different markers with OCT4 expression in three types of gastrointestinal cancers including esophageal, gastric and colorectal cancers. OCT4 through different signaling pathways has an impact on different processes of gastrointestinal cancers such as proliferation, invasion, and metastasis. Based on the literature, OCT4 has great effects on cancer progression at different stages, therefore we suggested it has potential implications in therapeutic options.
引用
收藏
页码:229 / 242
页数:14
相关论文
共 137 条
  • [1] Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis
    Al-Marzoqee, Fathyia Y.
    Khoder, Ghalia
    Al-Awadhi, Haifa
    John, Rony
    Beg, Azam
    Vincze, Aron
    Branicki, Frank
    Karam, Sherif M.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (05) : 1733 - 1743
  • [2] The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines
    Amini, Sabrieh
    Fathi, Fardin
    Mobalegi, Jafar
    Sofimajidpour, Heshmatollah
    Ghadimi, Tayyeb
    [J]. ANATOMY & CELL BIOLOGY, 2014, 47 (01) : 1 - 11
  • [3] Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells
    Amsterdam, Abraham
    Raanan, Calanit
    Schreiber, Letizia
    Freyhan, Ora
    Fabrikant, Yakov
    Melzer, Ehud
    Givol, David
    [J]. ACTA HISTOCHEMICA, 2013, 115 (04) : 320 - 329
  • [4] Pseudogenes regulate parental gene expression via ceRNA network
    An, Yang
    Furber, Kendra L.
    Ji, Shaoping
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (01) : 185 - 192
  • [5] [Anonymous], CLIN CANC RES
  • [6] OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor
    Asadi, Malek H.
    Mowla, Seyed J.
    Fathi, Fardin
    Aleyasin, Ahmad
    Asadzadeh, Jamshid
    Atlasi, Yaser
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (11) : 2645 - 2652
  • [7] OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells
    Atlasi, Yaser
    Mowla, Seyed J.
    Ziaee, Seyed A. M.
    Gokhale, Paul J.
    Andrews, Peter W.
    [J]. STEM CELLS, 2008, 26 (12) : 3068 - 3074
  • [8] Batsaikhan BE, 2014, ANTICANCER RES, V34, P6339
  • [9] Tumour heterogeneity in the clinic
    Bedard, Philippe L.
    Hansen, Aaron R.
    Ratain, Mark J.
    Siu, Lillian L.
    [J]. NATURE, 2013, 501 (7467) : 355 - 364
  • [10] Dysregulation of CDX1, CDX2 and SOX2 in patients with gastric cancer also affects the non-malignant mucosa
    Bornschein, Jan
    Toth, Kinga
    Selgrad, Michael
    Kuester, Doerthe
    Wex, Thomas
    Molnar, Bela
    Tulassay, Zsolt
    Malfertheiner, Peter
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (09) : 819 - 822